Satu Lakio

Mar 15, 2024 | outsourcedpharma.com | Louis Garguilo |Fred A. Rowley |Satu Lakio |Niklas Sandler

“BIO is taking steps now to separate from WuXi-AppTec regarding membership in the organization," says Biotechnology Innovation Organization President & CEO John F. Crowley. But to Chief Editor Louis Garguilo, this seems like a strange company to target. Is Precompression Tablet Thickness A True Critical Operating Parameter?

Mar 15, 2024 | outsourcedpharma.com | Louis Garguilo |Fred A. Rowley |Satu Lakio |Niklas Sandler

“BIO is taking steps now to separate from WuXi-AppTec regarding membership in the organization," says Biotechnology Innovation Organization President & CEO John F. Crowley. But to Chief Editor Louis Garguilo, this seems like a strange company to target. Is Precompression Tablet Thickness A True Critical Operating Parameter?

Feb 16, 2024 | pharmaceuticalonline.com | Erika Roberts |Ramesh Mullangi |Satu Lakio |Niklas Sandler

Webinar: Selecting Container Closure Systems With Confidence — LyophilizationJoin us March 7th as industry experts from West Pharmaceutical Services take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes. Click here to learn more. Benzene contamination in pharmaceuticals has led to product recalls and increased scrutiny.

Jun 22, 2023 | pharmaceuticalonline.com | Donielle McCutcheon |Kim Schroer |Carol Houts |Satu Lakio

By Donielle McCutcheon and Kim Schroer, Sidley Austin LLP For emerging drug companies on a tight budget, an effective healthcare compliance program can save precious resources by establishing better oversight, controls, and monitoring of the company’s quality, R&D, clinical, and market access activities. Such a program should be implemented in precommercial stages and will prepare you for the regulated future ahead.